Among them are people who have private insurance, but end up shouldering a large share of the cost directly because of high co-payments in their drug coverage. The Senate parliamentarian, who advises the chamber on procedural questions, ruled that the insulin cap for private insurance did not satisfy that requirement. The effort to cap insulin costs was not a total wash. But the insulin provision was one of the few that would directly affect people with private insurance. Such measures could help even people with no insurance, which the IRA insulin proposal for private insurance would not have.

Source: Huffington Post August 08, 2022 02:08 UTC